<DOC>
	<DOCNO>NCT00817648</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy seroquel treatment patient acute schizophrenia compare risperidone evaluate change PANSS total score baseline week 6 .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Seroquel Chinese Han Patients With Schizophrenia</brief_title>
	<detailed_description>This rater- blind , parallel assignment , randomize active control study . The subject investigate outpatient inpatient schizophrenia Chinese Han race . The screening phase last 1 week . The eligible patient enter next randomized treatment phase . The titration duration 1 week . After first week , patient administer flexible dose regimen . In study , effective dos range seroquel risperidone 600-750mg/d 3-6mg/d respectively treatment duration last 6 week . The efficacy safety seroquel treatment patient schizophrenia confirm multiple double blind study . This study design evaluate efficacy safety seroquel treatment Chinese Han patient schizophrenia . Therefore , single blind active control design select study . The drug titration method dose within range specify instruction patient schizophrenia tolerant drug clinical treatment . The purpose schizophrenic patient treatment improve core symptom , prevent suicide aggressive behavior , alleviate side reaction cause drug , recover life function patient . Generally , treatment acute phase last 6 8 week . In study , treatment acute phase last 6 week . The rating scale use study standard psychiatric rating scale good validity widely use study antischizophrenia drug treatment patient schizophrenia China . The PANSS develop two early rating scale , namely brief psychiatric rating scale ( BPRS ) psychiatric rating scale . The high inter-investigator reliability repeat measurement reliability scale prove multiple study . The clinical global impression ( CGI ) simple convenient global impression scale . It applicable patient treat studied psychiatric department . The Carlgary depression scale schizophrenia ( CDSS ) use evaluate depressive symptom patient schizophrenia . It good reliability validity . The abnormal involuntary movement scale ( AIMS ) another evaluation tool consist 12 item . The AIMS use evaluate abnormal involuntary movement relate antischizophrenia drug . The AIMS nearly frequently use multi-item rating scale evaluate tardive dyskinesia . The Simpson Angus scale ( SAS ) also rating scale commonly use since release 1970 . The validity SAS verify double blind placebo-controlled study involve two haloperidol dos .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Written inform consent provide legal guardian patient . 2 . Patients meet DSMIV criterion schizophrenia : 295.20 ( Schizophrenia , Catatonic Type ) , 295.10 ( Schizophrenia , Disorganized Type ) , 295.30 ( Schizophrenia , Paranoid Type ) , 295.60 ( Schizophrenia , Residual Type ) , 296.90 ( Mood Disorder NOS ) . 3 . Age 1865 year old , male female , Han nationality . 4 . PANSS total score least 70 baseline . 5 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment . 6 . Able understand comply requirement study . 1 . Pregnancy lactation . 2 . A diagnosis DSMIV Axis I disorder define inclusion criterion , except schizophrenia . 3 . Patients imminent risk suicide danger self others judge investigator . 4 . Known intolerance lack efficacy seroquel and/or risperidone , judge investigator . 5 . Use seroquel and/or risperidone within 28 day prior enrolment . 6 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir . 7 . Use follow cytochrome P450 inducer 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . 8 . Use long act antipsychotic Within one dose interval 9 . Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion . 10 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse define DSMIV criterion within 28 day prior enrolment . 11 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment . 12 . Unstable inadequately treat medical illness ( e.g . CHF congestive heart failure , angina pectoris , hypertension ) judge investigator . 13 . Involvement plan conduct study . 14 . Participation another drug trial within 28 day prior enrolment study . 15 . Patient diabetes mellitus . 16 . The patient 's absolute neutrophil count ( ANC ) â‰¤ 1.5 x 109/L ALT AST value liver function test exceed two time upper limit normal value . 17 . Use Electroconvulsive therapy within 28 day prior randomization . 18 . Use clozapine within 28 day prior randomization . 19 . Previous enrolment present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>quetiapine</keyword>
	<keyword>risperidone</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>multicenter</keyword>
	<keyword>rater-blind</keyword>
	<keyword>randomize</keyword>
	<keyword>chinese</keyword>
	<keyword>han</keyword>
</DOC>